Inhibition of FGF receptors for effective treatment of BRAF- and BRAF/MEK inhibitor-resistant melanoma cells

被引：0
|
作者：
Graf, S. A. [1 ]
Strieder, A. [1 ]
Meierjohann, S. [2 ]
Heppt, M. V. [1 ]
Kammerbauer, C. [1 ]
Berking, C. [1 ]
机构：
[1] Ludwig Maximilian Univ Munich, Dept Dermatol, D-80337 Munich, Germany
[2] Univ Wurzburg, Dept Physiol Chem, D-97074 Wurzburg, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2017年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
15(OP02/05
引用
下载
收藏
页码：E92 / E92
页数：1
相关论文
共 50 条
  • [21] Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
    Smalley, Keiran S. M.
    Fedorenko, Inna V.
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (04)
  • [22] p90RSK Blockade Inhibits Dual BRAF and MEK Inhibitor-Resistant Melanoma by Targeting Protein Synthesis
    Theodosakis, Nicholas
    Micevic, Goran
    Langdon, Casey G.
    Ventura, Alessandra
    Means, Robert
    Stern, David F.
    Bosenberg, Marcus W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : 2187 - 2196
  • [23] Combined inhibition of BRAF and MEK in melanoma patients
    Infante, Jeffrey R.
    Swanton, Charles
    LANCET ONCOLOGY, 2014, 15 (09): : 908 - 910
  • [24] MEK Inhibition in BRAF-Mutated Melanoma
    Ascierto, Paolo A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1364 - 1364
  • [25] BRAF Inhibitor Encorafenib plus MEK Inhibitor Binimetinib is effective in leptomeningeal Metastasis of Melanoma
    Steininger, J.
    Kuske, M.
    Beissert, S.
    Meier, F.
    Becker, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 83 - 84
  • [26] Successful Combination Therapy of BRAF- and MEK-Inhibitor after Progress under BRAF-Inhibitor Mono Therapy: Report of a Patient with brain metastatic Melanoma
    Asper, H.
    Satger, I
    Tolk, H.
    Kapp, A.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 166 - 166
  • [27] Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
    Flaherty, Keith T.
    Infante, Jeffery R.
    Daud, Adil
    Gonzalez, Rene
    Kefford, Richard F.
    Sosman, Jeffrey
    Hamid, Omid
    Schuchter, Lynn
    Cebon, Jonathan
    Ibrahim, Nageatte
    Kudchadkar, Ragini
    Burris, Howard A., III
    Falchook, Gerald
    Algazi, Alain
    Lewis, Karl
    Long, Georgina V.
    Puzanov, Igor
    Lebowitz, Peter
    Singh, Ajay
    Little, Shonda
    Sun, Peng
    Allred, Alicia
    Ouellet, Daniele
    Kim, Kevin B.
    Patel, Kiran
    Weber, Jeffrey
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (18): : 1694 - 1703
  • [28] Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance
    Martin, Claire A.
    Cullinane, Carleen
    Kirby, Laura
    Abuhammad, Shatha
    Lelliott, Emily J.
    Waldeck, Kelly
    Young, Richard J.
    Brajanovski, Natalie
    Cameron, Donald P.
    Walker, Rachael
    Sanij, Elaine
    Poortinga, Gretchen
    Hannan, Ross D.
    Pearson, Richard B.
    Hicks, Rodney J.
    McArthur, Grant A.
    Sheppard, Karen E.
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (10) : 2139 - 2152
  • [29] Intratumoral Molecular Heterogeneity in a BRAF-Mutant, BRAF Inhibitor-Resistant Melanoma: A Case Illustrating the Challenges for Personalized Medicine
    Wilmott, James S.
    Tembe, Varsha
    Howle, Julie R.
    Sharma, Raghwa
    Thompson, John F.
    Rizos, Helen
    Lo, Roger S.
    Kefford, Richard F.
    Scolyer, Richard A.
    Long, Georgina V.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2704 - 2708
  • [30] Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations
    Stamatakos, Serena
    Beretta, Giovanni Luca
    Vergani, Elisabetta
    Dugo, Matteo
    Corno, Cristina
    Corna, Elisabetta
    Tinelli, Stella
    Frigerio, Simona
    Ciusani, Emilio
    Rodolfo, Monica
    Perego, Paola
    Gatti, Laura
    CANCERS, 2021, 13 (09)
12345